What is Scotiabank’s Estimate for TSE:ATR FY2026 Earnings?

SNC-Lavalin Group Inc. (TSE:ATR) – Equities research analysts at Scotiabank decreased their FY2026 EPS estimates for SNC-Lavalin Group in a research report issued on Friday, April 17th. Scotiabank analyst J. Goldman now expects that the company will earn $3.75 per share for the year, down from their prior estimate of $3.79.

SNC-Lavalin Group Price Performance

About SNC-Lavalin Group

AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.